Buy-now, pay-later pioneer Zip (ASX:ZIP) has reaffirmed its FY26 earnings guidance, buoyed by a surge in transaction volumes and a commanding performance in the United States. Following a robust March ...
Australian household spending went up by 1.6% in March, marking an acceleration from the modest gains seen at the start of the year. Data released by the Australian Bureau of Statistics reveals that ...
JB Hi-Fi (ASX:JBH) CEO Nick Wells has issued a cautionary outlook for the final quarter of the financial year, citing a tightening supply chain and rising costs for consumer electronics. Addressing ...
Eve Holding (NYSE:EMBJ), the electric vertical takeoff and landing (eVTOL) subsidiary of Embraer, reported financial results for the first quarter ended March 31, 2026, characterized by a deliberate ...
Thermo Fisher Scientific (NYSE:TMO) announced on Monday that it has entered into a definitive agreement to sell its microbiology business to Astorg, a prominent pan-European private equity firm. The ...
Gentrack Group (ASX:GTK) has issued a market update revealing a strategic pivot towards global leadership and long-term expansion, even as it moderates its short-term financial outlook. The utility ...
Domino’s Pizza (NASDAQ:DPZ) reported its first-quarter 2026 financial results on Monday, revealing a resilient bottom line supported by robust international expansion despite softening demand in ...
Australian retail giant Eagers Automotive (ASX:APE) completed its acquisition of CanadaOne Auto. Effective April 30, Eagers secured a 65% majority stake in the holding company of CanadaOne, which is ...
China’s state planner has officially prohibited Meta Platforms' (NASDAQ:META) acquisition of artificial intelligence startup Manus, ordering the immediate cancellation of the transaction. The decision ...
Purple Biotech (NASDAQ:PPBT) released promising preclinical data on Monday for its lead therapeutic candidate, IM1240, demonstrating consistent anti-tumor activity across seven distinct ...
Eli Lilly (NYSE:LLY) has reached a definitive agreement to acquire Ajax Therapeutics, a biotechnology firm specializing in next-generation therapies for myeloproliferative neoplasms (MPNs). The deal, ...
The U.S. Food and Drug Administration has approved AstraZeneca’s (NASDAQ:AZN) Saphnelo (anifrolumab) for self-administration via a once-weekly autoinjector, the Saphnelo Pen. This new subcutaneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results